Clinical Trials on Malignant Neoplasms of Male Genital Organs in Japan
Total 476 results
-
Shoichi Fujii, MD, PhDUnknownMalignant Neoplasm of Transverse Colon | Malignant Neoplasm of Descending ColonJapan
-
Osamu UkimuraActive, not recruiting
-
Translational Research Center for Medical Innovation...The Jikei University School of MedicineCompleted
-
BayerActive, not recruitingProstatic Neoplasms, Castration-ResistantJapan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
SanofiCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
TakedaCompleted
-
Translational Research Center for Medical Innovation...Jikei University School of MedicineCompleted
-
BayerCompleted
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
SanofiCompletedTherapy, Prostatic NeoplasmsJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Translational Research Center for Medical Innovation...Kyoto University, Graduate School of MedicineCompletedProstate Cancer | Metastatic CancerJapan
-
Japan Study Group of Prostate CancerEnrolling by invitation
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
BayerCompleted
-
Janssen Pharmaceutical K.K.CompletedProstatic NeoplasmsJapan
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Norio NonomuraUnknownCastration Resistant Prostate CancerJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruitingProstate CancerJapan
-
AstraZenecaCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Bristol-Myers SquibbCompleted
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Eli Lilly and CompanyCompletedMetastasis | MalignancyJapan
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Bristol-Myers SquibbRecruiting
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Translational Research Center for Medical Innovation...Kurosawa HospitalCompleted
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Prostate Neoplasms | Castration Resistant Prostate Cancer (CRPC)Japan
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
NobelpharmaCompleted
-
European Organisation for Research and Treatment...Japan Clinical Oncology Group; European Society of Surgical OncologyCompletedColorectal Cancer | Colon Cancer Liver Metastasis | Malignant Neoplasm of Rectum Metastatic to LiverFrance, Japan, Belgium, United States, Austria
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
TakedaCompleted
-
SanofiCompleted
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Janssen Pharmaceutical K.K.CompletedMetastatic Castration-Resistant Prostate CancerJapan
-
BayerActive, not recruitingProstate CancerUnited States, Canada, Japan, Spain, Germany, Belgium, Argentina, Austria, Brazil, Greece, Italy, Russian Federation, Taiwan, China, Denmark, France, Colombia